Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livermore

Showing results (61-70 of 963) with videos related to

Pageof 97
Sort By:
Annals of Medicine|July 9, 2003
The threat from the pink cornerDavid M Livermore
The Journal of Antimicrobial Chemotherapy|February 1, 1992
Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamaseD M Livermore
The Journal of Antimicrobial Chemotherapy|June 1, 1987
Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of beta-lactamase activity by PBP-5D M Livermore
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1991
Mechanisms of resistance to beta-lactam antibioticsD M Livermore
Current Protein & Peptide Science|June 23, 2009
beta-Lactamases- the Threat RenewsDavid M Livermore
The Journal of Antimicrobial Chemotherapy|August 14, 2009
Has the era of untreatable infections arrived?David M Livermore
Science (New York, N.Y.)|January 7, 1977
Courses on Ethics and Values in Science to be SurveyedA H Livermore
Antibiotics and Chemotherapy|January 1, 1991
beta-Lactamases of Pseudomonas aeruginosaD M Livermore
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
The impact of carbapenemases on antimicrobial development and therapyDavid M Livermore
Social Security Bulletin|September 14, 2011
Social Security disability beneficiaries with work-related goals and expectationsGina A Livermore
Pageof 97

Showing results (61-70 of 963) with videos related to

Sort By:
Pageof 97
Annals of Medicine|July 9, 2003
The threat from the pink cornerDavid M Livermore
The Journal of Antimicrobial Chemotherapy|February 1, 1992
Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamaseD M Livermore
The Journal of Antimicrobial Chemotherapy|June 1, 1987
Radiolabelling of penicillin-binding proteins (PBPs) in intact Pseudomonas aeruginosa cells: consequences of beta-lactamase activity by PBP-5D M Livermore
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1991
Mechanisms of resistance to beta-lactam antibioticsD M Livermore
Current Protein & Peptide Science|June 23, 2009
beta-Lactamases- the Threat RenewsDavid M Livermore
The Journal of Antimicrobial Chemotherapy|August 14, 2009
Has the era of untreatable infections arrived?David M Livermore
Science (New York, N.Y.)|January 7, 1977
Courses on Ethics and Values in Science to be SurveyedA H Livermore
Antibiotics and Chemotherapy|January 1, 1991
beta-Lactamases of Pseudomonas aeruginosaD M Livermore
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
The impact of carbapenemases on antimicrobial development and therapyDavid M Livermore
Social Security Bulletin|September 14, 2011
Social Security disability beneficiaries with work-related goals and expectationsGina A Livermore
Pageof 97